Novartis and Sandoz are recalling several blister packaged prescription medications because they fail to meet child-resistant closure requirements as required by the Poison Prevention Package Act. The companies have received one report of a child consuming the antipsychotic haloperidol from a blister pack. The recall affects about 470,000 units and includes drugs packaged with 3 to 10 tablets per blister card. The blister packs were designed for use in hospitals but some were sent to retail pharmacies and were likely dispensed for in-home use. Novartis products affected by the recall include the anti-nausea drug Zofran ODT (ondansetron) 4mg and 8 ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.